Rocket


Overview
Financials
News + Filings
Key Docs
Transactions
Holdings
Ownership

UBS Group AG > PRLD

DateNameTickerSharesChangeValueChangePrice
06/30/2023Prelude Therapeutics IncPRLD6,8925,91231,015,00025,429,000$4,500.15
03/31/2023Prelude Therapeutics IncPRLD980-575,586,000-677,000$5,700.00
12/31/2022Prelude Therapeutics IncPRLD1,0371,0376,263,0006,263,000$6,039.54
09/30/2022Prelude Therapeutics IncPRLD0-2,7060-14,000 
06/30/2022Prelude Therapeutics IncPRLD2,7062,52314,00013,000$5.17
03/31/2022Prelude Therapeutics IncPRLD183-1,7551,000-22,000$5.46
12/31/2021Prelude Therapeutics IncPRLD1,938-35,06323,000-1,134,000$11.87
09/30/2021Prelude Therapeutics IncPRLD37,00129,4331,157,000941,000$31.27
06/30/2021Prelude Therapeutics IncPRLD7,5684,987216,00031,000$28.54
12/31/2020Prelude Therapeutics IncPRLD2,5811,158185,000142,000$71.68
09/30/2020Prelude Therapeutics IncPRLD1,4231,42343,00043,000$30.22
<< Prev     Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy